Additionally, metformin promotes ferroptosis in breast cancer cells by inducing UFMylation modification of SLC7A11, independently of the AMPK signaling pathway, revealing a novel anticancer mechanism of metformin (110). Here, SLC7A11 is linked to breast cancer.